The patient with the MSH6*p.Y433X truncation also had endometrial cancer, this patient also harbored unclassified variants in MUTYH and BRCA2. The patient with CHEK2*c.1100delC was identified with serous carcinoma. This evidence concerns the gene CHEK2 and serous adenocarcinoma.